Red blood cell transfusion and outcome in cancer

Nayyer Iqbal, Kamal Haider, Vinita Sundaram, Julia Radosevic, Thierry Burnouf, Jerard Seghatchian, Hadi Goubran

研究成果: 雜誌貢獻回顧型文獻同行評審

25 引文 斯高帕斯(Scopus)

摘要

Oncology services utilize about 15% of the blood transfusion resources in the USA. Red blood cell transfusion is performed immediately before, during or after major surgery to compensate for blood loss and hemodilution. However, a lack of evidence-based guidelines leads to variable transfusion practices among clinicians. The benefits of transfusing blood products are obvious in life-threatening low blood cell counts or bleeding, but it is becoming apparent that deliberate blood transfusion in some cancer patients can trigger negative clinical impacts. This review attempts to provide an overview of the impact of red blood cell transfusion in patients suffering from various types of oncologic pathologies.
原文英語
頁(從 - 到)287-290
頁數4
期刊Transfusion and Apheresis Science
56
發行號3
DOIs
出版狀態已發佈 - 6月 1 2017

ASJC Scopus subject areas

  • 血液學

指紋

深入研究「Red blood cell transfusion and outcome in cancer」主題。共同形成了獨特的指紋。

引用此